Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Molecular Pharmaceutics
|
December 7, 2023
iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
March 13, 2025
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
Ben Forbes, Per Bäckman, Antonio Cabal, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 11, 2022
Current practices for QSP model assessment: an IQ consortium survey
Jason R Chan, Richard Allen, Britton Boras, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 10, 2016
Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions
Michael Caniga, Antonio Cabal, Khamir Mehta, et al.
Bone
|
June 25, 2013
High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate
Antonio Cabal, Richa Y Jayakar, Swanand Sardesai, et al.
Bone
|
June 29, 2013
Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate
Donald S Williams, Paul J McCracken, Mona Purcell, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Molecular Pharmaceutics
|
December 7, 2023
iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
March 13, 2025
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
Ben Forbes, Per Bäckman, Antonio Cabal, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 11, 2022
Current practices for QSP model assessment: an IQ consortium survey
Jason R Chan, Richard Allen, Britton Boras, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 10, 2016
Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions
Michael Caniga, Antonio Cabal, Khamir Mehta, et al.
Bone
|
June 25, 2013
High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate
Antonio Cabal, Richa Y Jayakar, Swanand Sardesai, et al.
Bone
|
June 29, 2013
Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate
Donald S Williams, Paul J McCracken, Mona Purcell, et al.
Page
of 2